|
*
Low birth weight as a risk factor for chronic kidney disease
|
№3 / 2010
|
|
V.V. Fomin, S.S. Girina
Perspectives on long-acting dihydropiridine calcium antagonists in treatment and prophylaxis of chronic kidney disease
|
№2 / 2010
|
|
V.V. Fomin, M.A. Rasuvaeva
What is the real target blood pressure in patients with arterial hypertension without diabetes mellitus type 2?
|
№1 / 2010
|
|
S.V. Moisseev, V.V. Fomin
Loop diuretics in arterial hypertension treatment: forgotten past or bright future?
|
№1 / 2010
|
|
L.A. Alekseeva, L.A. Popova, I.V. Ryzhenkova
Arterial hypertension and chronic renal failure in patients on long-term ambulatory management
|
№1 / 2010
|
|
M.L. Nanchikeeva, L.V. Kozlovskaya, V.V. Fomin, I.N. Bobkova, V.V. Rameev
Clinical significance of determination or urinary concentration of endothelial dysfunction and fibrogenesis markers in hypertensive nephropathy
|
№4 / 2009
|
|
A.S. Donskov
Ambulatory blood pressure monitoring in patients with arterial hypertension stages I – II with uric acid metabolism abnormalities
|
№4 / 2009
|
|
Salt dietary consumption and arterial hypertension: time for action
|
№4 / 2009
|
|
Fomin V.V.
Can we manage arterial hypertension without hydrochlorothiazide?
|
№3 / 2009
|
|
M.V. Lebedeva, T.Yu. Stakhova, I.M. Balkarov, E.G. Minakova, L.I. Zaitseva, M.M. Severova, T.N. Shovskaya
Albuminuria, plasma endothelin-1 and carotid atherosclerosis in patients with arterial hypertension and hyperuricemia
|
№3 / 2009
|
|
G.P. Arutyunov, MD, PhD, Prof; L.G. Oganezova, MD
Beta-blockers and renal continuum
|
№2 / 2009
|
|
M.M. Batiushin MD, PhD, Prof, E.S. Postnikova, MD, V.P. Terentiev MD, PhD, Prof, I.V. Dereviankina, MD
Correction of cerebro-renal syndrome in arterial hypertension with ischemic stroke: efficacy of eprosartan and hydrochlorothiazide
|
№1 / 2009
|
Русский
